Your browser doesn't support javascript.
loading
A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignancies.
Trivedi, Neel D; Armstrong, Samantha; Wang, Hongkun; Hartley, Marion; Deeken, John; Ruth He, A; Subramaniam, Deepa; Melville, Heather; Albanese, Chris; Marshall, John L; Hwang, Jimmy; Pishvaian, Michael J.
Afiliación
  • Trivedi ND; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
  • Armstrong S; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
  • Wang H; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
  • Hartley M; The Ruesch Center for the Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
  • Deeken J; Inova Schar Cancer Institute, Inova Health System, Falls Church, VA, USA.
  • Ruth He A; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
  • Subramaniam D; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
  • Melville H; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
  • Albanese C; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
  • Marshall JL; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
  • Hwang J; Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA.
  • Pishvaian MJ; Department of Oncology, Johns Hopkins University School of Medicine, SKCC, Washington, DC, USA.
Cancer Med ; 10(6): 1944-1954, 2021 03.
Article en En | MEDLINE | ID: mdl-33638305
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Sirolimus / Serina-Treonina Quinasas TOR / Capecitabina / Neoplasias / Antineoplásicos Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Sirolimus / Serina-Treonina Quinasas TOR / Capecitabina / Neoplasias / Antineoplásicos Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos